Eye Laser Industry Sees Minimal Impact From FDA LASIK Panel Meeting

Laser vision correction device makers likely will not see major, direct fallout from a recent FDA panel meeting examining patient quality-of-life issues following laser-assisted in situ keratomileusis (LASIK), according to industry

More from Archive

More from Medtech Insight